S. Fagan

Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease

K. Dev, S. O'Sullivan, J. Yssel, 2020, The Journal of Neuroscience.

Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL‐1β drives amplified responses in primed astrocytes and neuronal network dysfunction

M. Cunningham, C. Cunningham, D. Boche, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

The influence of cannabinoids on generic traits of neurodegeneration

V. Campbell, S. Fagan, 2014, British journal of pharmacology.

tRNA-derived fragments: A new class of non-coding RNA with key roles in nervous system function and dysfunction

M. Helm, J. Prehn, S. Fagan, 2021, Progress in Neurobiology.

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer’s Disease

K. Dev, S. Béchet, S. Fagan, 2022, Molecular Neurobiology.

Mapping the binding site topology of amyloid protein aggregates using multivalent ligands†

D. Klenerman, M. Spillantini, F. Aigbirhio, 2021, Chemical science.

Microglial and Astrocyte priming in the APP/PS1 model of Alzheimer’s Disease: increased vulnerability to acute inflammation and cognitive deficits

C. Cunningham, A. Lopez-Rodriguez, Arshed Nazmi, 2018, bioRxiv.

Endocannabinoids and Alzheimer’s disease

V. Campbell, S. Fagan, 2015 .

Synthesis and Assessment of Novel Probes for Imaging Tau Pathology in Transgenic Mouse and Rat Models

M. Goedert, M. Spillantini, A. Tolkovsky, 2021, ACS chemical neuroscience.